Stock DARE DARÉ BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Daré Bioscience, Inc.

Equities

DARE

US23666P1012

Delayed Nasdaq
Other stock markets
 10:00:53 2024-04-25 am EDT 		5-day change 1st Jan Change
0.28 USD -2.10% Intraday chart for Daré Bioscience, Inc. -5.12% -9.39%
Apr. 23 Daré Bioscience, Inc. Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1 CI
Mar. 28 Transcript : Daré Bioscience, Inc., 2023 Earnings Call, Mar 28, 2024

Evolution of the average Target Price on Daré Bioscience, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2a94ac2ec5fc72.LSoS5Jcx7bTn6vnBsm_flRX-sOpEJS0l5MJDVRASJ_s.dUxalf16nIyLiY2o-hiS5FCw5Kx1EkVnyZA5IkIiS4NEQGqoukKgx9-koA~f5c33b32042cd1052536932f9d69f2cc

Analyst Recommendations on Daré Bioscience, Inc.

HC Wainwright Trims Price Target on Dare Bioscience to $6 From $7, Keeps Buy Rating MT
HC Wainwright Raises Price Target on Dare Bioscience to $7 From $6, Reiterates Buy Rating MT
JonesTrading Starts Dare Bioscience at Buy With $6 Price Target MT
Roth Capital Raises Price Target for Dare Bioscience to $17 From $11, Maintains Buy Rating MT
HC Wainwright Adjusts Dare Bioscience's Price Target to $6 from $5, Keeps Buy Rating MT
DARE BIOSCIENCE : Roth Capital Adjusts Price Target on Dare Bioscience to $11 From $9, Maintains Buy Rating MT
DARE BIOSCIENCE : HC Wainwright Initiates Coverage on Dare Bioscience With Buy Rating, $5 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.286 USD
Average target price
4 USD
Spread / Average Target
+1,298.60%
High Price Target
6 USD
Spread / Highest target
+1,997.90%
Low Price Target
2 USD
Spread / Lowest Target
+599.30%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Daré Bioscience, Inc.

HC Wainwright
JonesTrading Institutional Services
Roth Capital Partners

Ratings for Daré Bioscience, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. DARE Stock
  4. Consensus Daré Bioscience, Inc.